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Abstract 
 
Exposure to mycotoxins through dietary food intake involves a highly complex scenario 
where co-contamination of different mycotoxins has been frequently demonstrated. On 
the other hand, the effect of the interaction of mycotoxins with other generally considered 
beneficial food components, as the antioxidants, has been scarcely studied. The main goal 
of the present work was to assess the cytotoxic effects on Caco-2 cells of the mycotoxins 
deoxynivalenol (DON) and ochratoxin A (OTA), alone or combined, and to explore 
potential protective effects of resveratrol (RES), an antioxidant frequently found in wine. 
In parallel, reactive oxygen species (ROS) production has also been studied as a first 
approach to understand the underlying mechanism of cytotoxicity. Results indicate a 
higher toxic effect of the mycotoxins when they are co-exposed. This increase in 
cytotoxicity was not accompanied by an increase in ROS production. Opposite to our 
expectations, the co-exposure with RES didn’t result in a protection for the cell line from 
the mycotoxins, resulting in an increase in cytotoxicity at sub-toxic doses unrelated with 
an increase in ROS production. 
 
 
Keywords: Antioxidant; mycotoxin co-exposition; in vitro cytotoxicity; oxidative stress; 
ROS production. 
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1. Introduction 
 
Ochratoxin A (OTA) (Fig. 1a) is a fungal secondary metabolite produced by some 
species of the genera Aspergillus and Penicillium. Sources of human exposure to OTA 
are mainly foodstuffs of vegetal origin, such as cereals and derivatives, grapes, musts and 
wines, coffee, beer, nuts and dried fruits, spices and, to a minor extent, animal by-
products. OTA is a potent kidney toxin and has been classified by the IARC as a 2B 
cancer compound (possibly carcinogenic to humans) (IARC, 1993). It is among the 
strongest carcinogenic compounds in rats and mice, and its toxicological profile includes 
teratogenesis, nephrotoxicity and immunotoxicity (Fernández-Cruz et al., 2010). 
Reported in vitro toxic effects of OTA include inhibition of cellular proliferation, 
apoptosis and impairment of barrier function and increasing membrane permeability 
(McLaughlin et al., 2004). OTA has been found to induce oxidative damage in vitro 
(Schaaf et al., 2002; Kamp et al., 2005; Mally et al., 2005) and in vivo (Petrik et al., 2003; 
Hsuuw et al., 2013) and to be genotoxic (Lebrun and Föllmann, 2002; González-Arias et 
al., 2014). 
 
Figure 1. Molecular structure of (a) ochratoxin A, (b) deoxynivalenol and (c) resveratrol 
 
Deoxynivalenol (DON) (Fig. 1b), is one of the most common fungal contaminants 
of cereals worldwide. This mycotoxin is produced by different species of Fusarium, thus 
a wide range of cereal-based foods have been reported to be contaminated by this toxin 
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(JECFA, 2001). Acute effects of food poisoning by DON in humans are abdominal pains, 
dizziness, headache, throat irritation, nausea, vomiting, diarrhoea, and blood in the stool. 
It has also been shown that DON can act severely against the intestinal cells causing 
inflammation and increasing the permeability of the monolayers, resulting in a reduction 
of viability and immune function (Pinton et al., 2009; Van de Walle et al., 2010). DON 
also increases cytokine levels, a fact that is closely related with immune function 
reduction and increases caspase-3 levels, a well-known apoptosis mediator (Pestka et al., 
2004; Pestka, 2008). Additionally, DON induced oxidative stress has been proposed as 
the mechanism of DNA damage in hepatic cells HepG2 (Pestka et al., 2004). 
Red wine is one of the most important beverages in the Mediterranean diet, and it 
is considered to have a more protective effect than white wine due to its greater content 
in antioxidant substances released from the grape’s skin and seeds, mainly polyphenols. 
Red wine contains a total of 1.8 g/L of polyphenols, whereas white wine contains only 
0.2-0.3 g/L of polyphenols (Bertelli and Das, 2009). Resveratrol (RES; Fig. 1c), a 
polyphenolic product synthesized by a wide variety of plant fruits, including grapes, is 
naturally present in red wine. RES has gained considerable attention because of its 
potential as a chemopreventive and its anticancer properties, as well as for the evidence 
of decreasing heart disease and neural degeneration in animal studies (Vang et al., 2011). 
Among its various biological actions, RES was demonstrated to inhibit cellular survival 
signaling, and to interfere with apoptosis pathways, both by directly triggering apoptosis-
promoting signaling cascades and by blocking antiapoptotic mechanisms (Fulda and 
Debatin, 2006).  
Human dietary intake of food and its relationships with the digestive tract make 
up a very complex system in the framework of exposure to food contaminants. Most 
toxicity studies commonly evaluate the effect of individual mycotoxins on the target cell 
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biological functions. However human exposure to mycotoxins is well-known to be far off 
this simplified paradigm, involving sophisticated interactions with a lot of different 
matrices and different chemical species, including other mycotoxins, but also major 
nutrients, fibres and natural bioactive compounds. Co-contamination of different 
mycotoxins in food and feed has been frequently demonstrated, being a more common 
event than single contamination (Streit et al., 2013). Most of the published studies are 
reporting the toxicological properties of mycotoxins alone, and little is known concerning 
the effect of a specific mycotoxin mixed with other mycotoxins and/or with bioactive 
compounds, which may lead to unexpected subsequent effects. DON and OTA have 
shown to be among the most ubiquitous mycotoxins in foods of Mediterranean countries, 
and thus, continuously consumed in moderate levels through dietary intake. Moreover, 
the mycotoxin mixtures can interact with complex food matrices containing bioactive 
food compounds, as RES. Polyphenols such as RES are also widely present in the diet 
with the main dietary sources being fruits, wine, tea, coffee or chocolate (Burns et al., 
2002; Fernández-Mar et al., 2012). These compounds are known for their beneficial 
effects on human health due to their antioxidants properties. Thus, the main goal of the 
present work was to assess the effect of DON and OTA on the viability of Caco-2 cells 
when these mycotoxins are combined with RES. Additionally, to try to understand the 
underlying mechanism of cytotoxicity, production of reactive oxygen species (ROS), as 
a first indicator of oxidative stress status, has been measured. 
 
2. Materials and methods 
 
2.1 Chemicals 
 
6 
 
DON (3α, 7α, 15-trihydroxy-12,13-epoxytrichotech-9-en-8-one, purity ≥ 98 %), 
OTA ((2S)-2-{[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-
benzopyran-7-yl]formamido}-3-phenylpropanoic acid, purity ≥ 98%), RES (3,40,5-
trihydroxystilbene, purity ≥ 99%), trypsine, dimethylsulfoxide (DMSO), L-glutamine 
(200 mM), penicillin-streptomycin (10,000 UI/mL-10,000 µg/mL), Minimum Essential 
Medium (MEM, ref 56416C, dry powder), MEM non-essential amino acids 100x 
(NEAA), Hepes (Bio-performance grade), chloramine-T and 2’,7’-dichlorofluorescein 
diacetate (DCFH-DA) were purchased from Sigma-Aldrich (Sigma, Madrid, Spain). 
Dulbecco’s Modified Eagle Medium (DMEM, ref. SH30022) was supplied by Thermo 
Scientific HyClone (Barcelona, Spain) and fetal bovine serum (FBS) by Biosera (Santa 
Coloma de Gramenet, Spain). CellTiter 96® Aqueous Non-Radioactive Cell Proliferation 
Assay (MTS) kit was purchased from Promega (Charbonnières, France). Solid phase 
extraction cartridge BondElut C18 was purchased from Varian (California, USA). 
 
2.2 Cell culture and treatment 
 
The Caco-2 cell line (ATCC HTB-37) derived from a human colorectal 
adenocarcinoma was purchased from LGC Standards, S.a.r.l. (Molsheim Cedex, France). 
Caco-2 cells were cultured at 37 ºC and 5 % CO2 in DMEM medium supplemented with 
penicillin (100 UI/mL), streptomycin (100 μg/mL), 15 % fetal bovine serum, 2 mM L-
glutamine, and 1% NEAA. DON, OTA and RES were dissolved in DMSO and stored at 
-20 °C before dilution in cell culture media. Solvent control cells received the maximal 
DMSO concentrations used in the treated cells (0.1%, v/v). Caco-2 cells were seeded at 
a concentration of 105 cells/well in 100 μL of culture medium in flat-bottomed 96-well 
plates. After culturing for 48 h, different concentrations of OTA, DON and RES or their 
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combinations (OTA-RES, DON-RES, OTA-DON) were added to the cells. Cell lines 
were exposed for 6, 24 and/or 48 h, depending on the assay. 
 
2.3 Stability of resveratrol in the culture medium 
 
Yang et al. (2010) reported the oxidation of resveratrol in culture medium due to 
bicarbonate ions. We checked the stability of resveratrol (160 µM) in two culture media, 
MEM (medium without bicarbonate) and DMEM (a medium that contains 3.7 g/L of 
bicarbonate). Hepes (25 mM) was added to MEM to maintain the pH in a range of 7.2-
7.5. 
Stability assays were carried out with 3 mL of culture medium (spiked at 160 µM 
RES). Samples were incubated at 37 °C for 12, 24 and 48 h in the same conditions 
described for cell culture. Three culture medium samples were incubated for each time. 
Samples were collected at the end of the incubation period, and RES was extracted 
immediately. 
 
2.4 Solid-phase extraction of resveratrol and high performance liquid chromatography 
analysis (HPLC) 
 
RES from culture medium samples was extracted by solid-phase extraction using 
a Bond Elut C18 cartridge and ethanol as eluting solvent. Samples were dried under a 
nitrogen stream and stored at 4 ºC until analysis. 
RES was quantified by HPLC, using a Waters 2695 Separations Module coupled 
to a Waters 2475 Multi λ fluorescence detector (Waters, Milford, MA, USA). HPLC 
conditions were a modification of those described by Serra et al. (2009). Mobile phase 
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was: A) acetic acid 0.2% and B) acetonitrile, according to the following gradient: 0-10 
min 95% A, 10-20 min 75% A, 20-25 min 95% A, with a flow-rate of 1 mL/min. A Waters 
Spherisorb ODS2 C18 column (3 μm, 4.6 x 250 mm) was used and column temperature 
was maintained at 30 ºC during analysis. Detection was performed at 280 nm, and 
retention time was 14.66 min. Quantification was achieved with a software integrator 
(Empower 2, Milford, MA, USA). 
RES detection (LOD) and quantification (LOQ) limits were experimentally 
determined from the calibration curve of a set of seven standards (from 1 to 320 µM 
RES), which was linear in the range of 10-320 µM RES (r2 = 0.989). The LOD and LOQ 
determined was 10 and 25 µM, respectively. 
 
2.5 MTS assay 
 
The effects on the mitochondrial activity of Caco-2 cells exposed to OTA and 
RES at concentrations ranging from 0.5 to 160 µM and DON (0.25-30 µM), and the 
combinations of OTA (20, 40 and 80 µM) or DON (0.5, 1 and 5 µM) with RES (1-100 
µM), and OTA (20, 40 and 80 µM) with DON (0.5, 1 and 5 µM), after a 24 and 48 h 
exposure period, were studied using the MTS assay kit. The kit is composed of a 
tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium] (MTS) and phenazinemethosulfate (PMS), an electron 
coupling reagent. MTS is reduced by dehydrogenase enzymes in metabolically active 
cells into a formazan product that is soluble in tissue culture medium. After the 24 h or 
48 h exposure period, the cells were washed with PBS, and 20 μL of a freshly prepared 
MTS/PMS solution in fresh medium was added to the wells. The cells were further 
incubated for 2-4 h. The amount of soluble formazan produced by cellular reduction of 
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the MTS was measured by the absorbance at 490 nm on an ELISA plate reader (Genios, 
TECAN, Männedorf, Switzerland). Results were expressed as percentage of the solvent 
control. 
 
2.6 Reactive oxygen species (ROS) assay 
 
To study the ROS production, cells were exposed for 6, 24 and 48 h to OTA and 
RES at concentrations ranging from 0.5 to 160 µM, and DON at 0.25-30 µM. For the 
combination effects study, concentrations of OTA (5 and 80 µM) or DON (1 and 30 µM) 
with RES (10, 40 and 160 µM), and OTA (5 and 80 µM) with DON (1, 10 and 30 µM) 
were tested. Intracellular ROS production was determined by using the 
dichlorofluorescein (DCF) assay (Wang and Joseph, 1999). DCFH-DA (100 mM) in 
phenol red and serum-free MEM medium was added after the incubation period and 
maintained during 30 min at 37 ºC in the dark. Chloramine-T, an effective inducer of 
oxidative stress, was used as a positive control, with cells being exposed to concentrations 
in the range of 0.3-10 mM. Fluorescence was measured at 485 nm excitation and 535 nm 
emission at 37 ºC, using a microplate reader. Fluorescence readings were taken every 15 
min for 60 min, with the plates being incubated at 37 ºC with 5 % CO2 between 
measurements. Oxidative stress was calculated as the percentage of increase in 
fluorescence (Ft) per well over a 60-min period by the formula [(Ft60-Ft0)/Ft0 x 100]. 
This result was expressed as percentage of the solvent control. 
 
2.7 Statistical analysis 
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The sodium bicarbonate effect on stability of RES in culture medium was 
determined by the analysis of variance ANOVA and the Bonferroni post-test. 
Cytotoxicity data are represented as mean ± standard deviation (SD) of three to five 
independent experiments (in each experiment, each concentration was applied by 
triplicate in the culture plates). Statistical analysis was performed using Sigma Plot 
version 12.0 (Jandel Scientific, San Rafael, CA, USA). Significant differences among 
treatments were determined by one-way repeated measures analysis of variance 
(RMANOVA, p < 0.05). Previously, normality (Shapiro-Wilk test, p < 0.05) and equal 
variance (p < 0.05) of the distribution was tested. Means of treatments were contrasted 
with respect to the control group using Dunnett’s test.  
 
3. Results 
 
3.1. Stability of resveratrol in culture media. 
 
Table 1 reports the decrease of RES (160 µM) over time (12-48 h) on a culture medium 
with or without bicarbonate. Results showed that RES concentration decreased with time 
in both culture media used, regardless the presence of sodium bicarbonate in its 
composition. The decrease in RES level was moderate (10.5% loss) in samples incubated 
for 12 h in culture media with sodium bicarbonate (p < 0.05), and were increasing with 
time (19 to 41% after 24 and 48 h, respectively). Our results also show a statistical 
difference in RES levels due to the presence or absence of bicarbonate in the media .RES 
showed a moderate decrease after 24 h incubation in DMEM (19%), lower than in MEM 
(32.3%). However, at 48 h a minor decrease was observed in MEM (30.6%) than in 
DMEM (41.4%).  
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Table 1. Decrease of RES (160 µM) in cell culture medium with or without sodium 
bicarbonate 
Incubation 
time 
(h) 
Resveratrol stability 
Medium with bicarbonate  
(DMEM) 
Medium without bicarbonate 
(MEM) 
RES (µM) (% RES loss) RES (µM) (% RES loss) 
12 143.18 ± 7.05* 10.51 n.d. n.d. 
24 129.70 ± 5.29**, 
A 
18.94 108.33 ± 9.22**, B 32.29 
48 93.84 ± 7.53**, A 41.35 111.09 ± 3.15 **, B 30.57 
Data are represented as mean ± SD of three analyses. n.d.: not determined. 
Stars indicate statistical differences regarding to RES control in DMEM medium (0 h) 
(*p < 0.05, **p < 0.0005).  
Different capital letters next to DMEM/MEM treatments, at the same time, mean 
significant differences (p < 0.005) due to bicarbonate. 
  
 
3.2 MTS assay 
 
The effect of OTA, DON and RES treatment on cell viability was tested by the 
MTS assay over 24 h and 48 h. Similar responses were observed between both times of 
exposure and only results after 48 h exposure are presented in Figure 2. A dose-response 
curve was obtained after OTA and DON treatment. A significant reduction in cell 
viability was observed with OTA at 40 µM (p < 0.01) (Fig. 2a) and DON 1 µM (p < 
0.001) (Fig. 2b). The non observed effect concentration (NOEC) for OTA and DON were 
20 and 0.5 µM, respectively. However, Caco-2 cells did not show any response after 
treatment with RES in the range 0-160 µM (Fig. 2c). 
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Figure 2. Effect of OTA (a), DON (b) and RES (c) on Caco-2 cell viability after 48 h 
exposure measured with the MTS assay. Results are expressed as percentage of viability 
compared with the solvent control (0.1% DMSO). Data are represented as mean ± SD of 
3-5 independent experiments. Statistical differences with respect to the controls are 
indicated (**p < 0.01, ***p < 0.001). 
 
The 48 h co-exposure of DON at non-toxic concentrations (0.5 µM) with increasing 
concentrations (1-100 µM) of RES induced an increase in cytotoxicity at a concentration 
of RES of 100 µM (p < 0.001) (Fig. 3a). However the cytotoxic effect at concentrations 
of DON of 1 and 5 µM was not significantly affected by the presence of RES. On the 
other hand, the cytotoxicity of OTA at 80 µM increased significantly (p < 0.05) when co-
exposed with 100 µM of RES (Fig. 3b). An increase in toxicity could also be observed 
when cells were co-exposed to a non toxic concentration of OTA (20 µM) and non toxic 
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or low concentrations (0.5 µM and 1 µM) of DON (Fig. 3c).
 
Figure 3. Combined effect of DON, OTA and RES on Caco-2 cell viability after 48 h of 
treatment. Results are expressed as percentage of viability compared with the solvent 
control (0.1% DMSO). Data are represented as mean ± SD of 3-5 independent 
experiments. Statistical differences with respect to the control of RES for each 
concentration level of DON (3a) or OTA (3b) and with respect to the control of DON for 
each concentration level of OTA (3c) are indicated (*p < 0.05, **p < 0.01, ***p < 0.001). 
3.3 Reactive oxygen species (ROS) production 
 
ROS produced by OTA, DON and RES was measured by comparison of 
fluorescence emitted by treated cells with the control using a dichlorofluorescein (DCF) 
assay (Fig. 4). Significant dose-dependent production of ROS was obtained when the cells 
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were treated with OTA and RES for 24 h (data not shown) and 48 h (Fig. 4a and 4b), but 
not when treated for only 6 h (data not shown). The best response was obtained after 48 
h. OTA and RES induced production of ROS at 80 and 20 µM (p < 0.01), respectively. 
However, there was not an increase in ROS production when Caco-2 cells were treated 
with DON during 6 and 24 h (data not shown) or 48 h (Fig. 4c). 
 
Figure 4. Individual effect of DON, OTA and RES on ROS production by Caco-2 cells 
after 48 h of treatment. Results are expressed as percentage of ROS production compared 
with the solvent control (0.1% DMSO). Data are represented as mean ± SD of 3-5 
independent experiments. Statistical differences with respect to the controls are indicated 
(*p < 0.05, **p < 0.01, ***p < 0.001). 
 
Binary mixtures of DON and OTA with different concentrations of RES (10, 40 
and 160 µM) were tested (Fig. 5). To study the effects of DON on the ROS production, a 
low and a high cytotoxic concentration of DON (1 µM and 30 µM) were selected for 
these co-exposure studies. RES produced a notable increase of ROS levels when it was 
treated individually, however this ROS production decreased completely when co-
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exposed with DON at both concentration levels (Fig. 5a). To study the effects of the co-
exposure of OTA with RES a non ROS-producing and non-cytotoxic concentration (5 
µM), and a high cytotoxic and high ROS-producing concentration (80 µM) of OTA were 
selected. Combination of OTA at both doses with RES blocked the production of ROS 
by RES (Fig. 5b). Mixtures of OTA-DON didn’t increase the ROS production observed 
for the highest concentration of OTA (80 µM) (Fig. 5c). 
 
Figure 5. Combined effect of DON, OTA and RES on ROS production by Caco-2 cells 
after 48 h of treatment. Results are expressed as percentage of ROS production compared 
with the solvent control (0.1% DMSO). Data are represented as mean ± SD of 3-5 
independent experiments. Statistical differences with respect to the control of RES for 
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each concentration level of DON (5a) or OTA (5b) and with respect to the control of DON 
for each concentration level of OTA (5c) are indicated (**p < 0.01). 
 
4. Discussion 
 
In this study we have used the human cell line Caco-2 to study the possible toxic 
effects of the presence in foods of two different mycotoxins when they are present alone 
or together as well as when the antioxidant RES is also present in food. Caco-2 cell model 
is an accepted intestinal model widely implemented to assess the effect of chemical 
compounds on the intestinal function. Hence, undifferentiated and proliferating Caco-2 
cells share some characteristics with crypt enterocytes. Studies focusing to assess the 
trans-cellular transport, barrier function and permeability properties are performed with 
differentiated cells, which exhibit structural and molecular characteristics similar to 
villous enterocytes. Cytotoxicity, viability and proliferation assays may be carried out 
also with un-differentiated (proliferating) Caco-2 phenotypes, which share some 
characteristics with crypt enterocytes (Manda et al. 2015; Sambruy et al 2001). Bony et 
al (2006) reported that proliferating cells were found to be more sensitive to DON than 
differentiated cells, therefore this model can be considered as the most conservative 
approach for hazard characterization. 
In the present work we have shown that the degradation of RES in DMEM, a 
medium with sodium bicarbonate, is lower than 20 % after 24 h of incubation and around 
40% after 48 h. These results do not agree with those found by Yang et al. (2010) that 
reported a 96 % of RES degradation after 24 h of incubation at 37 ºC when it was added 
at 200 µM to the Base Modified Eagle (BME) medium, a medium with bicarbonate (2.2 
g/L) in its composition. Our results also show that, independently of the presence or 
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absence of bicarbonate, the decrease in RES levels after 24 h (18.94% and 32.29%) and 
48 h (41.35% and 30.57%) of incubation is relatively similar.  
Regarding ROS production, Yang et al. (2010) reported a production of high 
levels (90 µM) of H2O2 after incubating RES for 24 h in a medium with bicarbonate. 
Nakamura et al. (2003) demonstrated a significant toxicity in HeLa cells after a 15 min 
exposure to H2O2 at concentrations as low as 0.06 mM (2 µg/mL). However, our results 
show that after 24 h and 48 h of exposure, RES is capable to increase ROS levels but not 
after 6 h, and no induction of cytotoxicity was observed with RES. This suggests that the 
enhanced production of ROS by RES in our study is mainly due to RES itself. 
Both assayed mycotoxins are cytotoxic for the Caco-2 cell line. The NOEC and 
the lowest observed effect concentration (LOEC) were 0.5 and 1 µM for DON and 20 and 
40 µM for OTA, respectively, indicating a highly toxic effect, especially for DON. 
Contrary to our results, Calvert et al. (2005) didn’t find cytotoxicity according to the MTT 
assay for the Caco-2 cell line after 48 h exposure to 0.34-1.7 µM of DON, but HeLa and 
Hep-2 cells were very sensitive to DON ≥ 0.34 µM. Also in the mammalian kidney 
epithelial (Vero) cells the cytotoxicity of DON, evaluated by the Neutral Red (NR) and 
MTT assays over 24, 48 and 72 h, showed IC50 values ranging from 3.30 to 10 µM (Ruiz 
et al., 2011). Berger et al. (2003) reported the toxic effect of OTA on Caco-2 cells with 
the MTT assay. They determined a low IC50 (0.4 µM) after a 48 h exposure period. 
However, similar results are reported in the HepG2 cell line. The IC50 of OTA, as 
measured by the NR assay and the MTT assay, was 35 µM after 24 and 48 h exposure 
(Hundhausen et al., 2005; Zheng et al., 2013). As expected, RES didn’t show cytotoxic 
effects up to concentrations of 160 µM. However, Sergent et al. (2005) found a slight 
cytotoxic effect of RES on Caco-2 cells after 48 h of treatment at 100 µM.  
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To investigate the capacity of these compounds and their combinations to induce 
oxidative stress, production of ROS was also measured. Studies carried out with 
individual compounds showed that only OTA and RES increased ROS levels with 
NOECs and LOECs of 40 and 80 µM for OTA and 10 and 20 µM for RES, respectively. 
The implication of oxidative stress in the cytotoxicity induced by OTA has been 
previously suggested (Schaaf et al., 2002; Petrik et al., 2003; Kamp et al., 2005; Mally et 
al., 2005; Hsuuw et al., 2013). In our study, the production of ROS is associated with a 
parallel reduction in viability, suggesting the same conclusion of other authors. 
Interestingly, although RES is known for its anti-oxidative properties, it was able to 
produce high levels of ROS at concentrations as low as 20 µM in the Caco-2 cell line. 
Juan et al. (2008) have also reported the generation of mitochondrial ROS in the human 
colon cancer cell line (HT-29) exposed to RES (150 µM) for 4 h. Despite this ROS 
production, the basal redox status of the cells was not disturbed and no cytotoxicity was 
recorded with this compound in the cell line studied. From our results, the cytotoxicity 
induced by DON might not be explained by an oxidative stress mechanism. Previous 
results points to an apoptotic mechanism (Petska et al., 2004; Pestka, 2008). Recently, 
Ma et al. (2012) demonstrated the capacity of DON to induce apoptosis in the HT-29 cell 
line at very low concentrations ranging from 0.8 to 3.4 µM. They showed that the 
mechanism of apoptosis was caused by mitochondrial dysfunction and subsequent release 
of cytochrome c into the cytoplasm and successive activation of caspase-9 and caspase-
3.  
There have been few works published to date attempting to contribute on the 
knowledge of mycotoxins interactions with bioactive compounds such as dietary 
polyphenols. The most common approach followed involves pre-treatments with the 
bioactive compound and a subsequent treatment with the mycotoxin (Hundhausen et al., 
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2005; Bosch-Saadatmandi et al., 2006; Costa et al., 2007). In real exposure scenarios, 
interactions between the bioactive compounds and mycotoxins will occur simultaneously, 
which suggest that pre-treatment may not be the best approach.  
In this study using a co-exposure approach, we didn’t found a protective effect 
when OTA was co-exposed with RES. In fact, co-exposure of OTA at concentrations of 
40 µM (moderately toxic dose) with the highest concentration of RES (100 µM) resulted 
in an increase in cytotoxicity. Sergent et al. (2005) showed that the Caco-2 absorption of 
OTA, at concentrations that should be easily encountered in the gut, is increased in the 
presence of RES. This would imply a greater bioavailability of the mycotoxin which 
could increase the toxicity of this compound. It could be that this also happens in the 
Caco-2 cell line, although this possibility has not been checked in this study. Co-exposure 
of DON with RES did neither result in a protective effect of the polyphenols to the toxic 
effects of this mycotoxin. Moreover, in the case of DON, the presence of RES at high 
doses (100 µM) increases the toxicity of a non-cytotoxic dose of DON (0.5 µM). In 
contrast, Kolesarova et al. (2012) showed in porcine ovarian granulosa cells that RES 
protected cells from the reproductive toxicity induced by DON. Co-exposure of OTA and 
DON with RES resulted in the complete abrogation of ROS levels induced by RES. This 
finding is difficult to explain especially in the case of the co-exposure of RES with the 
non-toxic and non-ROS producing dose of OTA (5 µM). The decrease in ROS production 
of RES observed when this compound is co-exposed with toxic doses of DON (1 µM and 
30 µM) or OTA (80 µM) could be the result of loss in cell viability. The mechanism 
triggering the cytotoxic effect of DON and OTA enhanced by RES at a non- toxic and a 
sub-toxic concentration respectively cannot be completely elucidated with the present 
data. Several studies have reported that RES modulates multiple vias that elicite to 
apoptosis and cell damage. Fouad et al. (2013) and Pasciu et al. (2010) have related a 
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response mediated by the caspase-3 and the cells damage observed. Zhai et al. (2015) 
reported that RES inhibits proliferation and induces apoptosis of fibroblasts through the 
mechanism involving transforming growth factor and Smad proteins (TGF-b1/Smads) 
signaling pathway. On the one hand, TGF-b1 is a multifunctional cytokine that controls 
a diverse set of cellular processes (cell proliferation, differentiation, and apoptosis). On 
the other hand, Smad proteins are downstream messengers of TGF-b signaling pathways, 
conveying the TGF-b-mediated extracellular signals to the nucleus (Zhai et al., 2015). 
 
When both mycotoxins were co-exposed at non-toxic concentrations of DON and 
OTA (0.5 and 20 µM, respectively) a significant increase in cytotoxicity was observed. 
Also the toxic response induced by DON (1 µM) increased significantly with increasing 
doses of OTA (40 and 80 µM), indicating that cocktails of these mycotoxins can suppose 
a risk for consumers. This increase in cytotoxicity could not be explained by an increase 
in ROS production. To our knowledge this is the first study where the in vitro toxicity of 
the co-exposure of DON and OTA has been studied. Other authors have reported different 
interactions between binary and tertiary combinations of DON or OTA with other 
mycotoxins (T-2 toxin, zearalenone, beauvericin, fumonisin B1, nivalenol, fusarenon-X) 
resulting in antagonism, synergism or additive effects depending on the combinations, 
the cell lines, the concentrations and the assays used (Ruiz et al., 2011; Alassane-Kpembi 
et al., 2013). 
Our results elucidated the complex behavior of mixtures of chemicals and 
bioactive compounds and the need of further research to better understand the biological 
responses and potential effects on the human health. Although the extrapolation of in vitro 
models to humans is very complex and requires an accurate approach, the concentration 
doses used in the present study are expected in the range of those levels expected from a 
21 
 
common European diet. For example, the mean and highest (percentile 95) exposure 
levels of DON in Spain were estimated to be 0.37 and 1.9 mg/kg bw/day (Cano-Sancho 
et al., 2011). Thus, a mean intestinal dose of 0.5 µM can be expected in a relevant group 
of population. RES can be detected in Spanish wine at mean concentrations of 4.6 mg/L 
(Martelo-Vidal and Vázquez, 2014), leading to estimate an intestinal dose of 20 µM. 
While the risk assessment frameworks are developed on the basis of animal or human 
dose-response studies with isolated mycotoxins, potential interactions with other 
mycotoxins and bioactive compounds are missed. We focused the study to assess the 
simultaneous exposure of DON and OTA, the most concerning mycotoxins in Spain 
(Cano-Sancho et al., 2011: Coronel et al. 2012) with RES, a polyphenol widely consumed 
on the Spanish households. Despite the risk characterization did not reveal a concern for 
the human health, in the present study we elucidated toxicological issues commonly 
misplaced on risk assessment, such as the potential interaction of bioactive compounds at 
sub-toxic doses of mycotoxins. Future studies should confirm these results on animal 
models and assess the interactions with other bioactive compounds, as well as to translate 
the effect of these interactions on the risk characterization frameworks. 
 
5. Conclusion 
 
The results from our study showed that the co-exposure of both mycotoxins increased 
significantly the cytotoxicity of these compounds in Caco-2 cells without increasing the 
ROS production. Opposite to our expectations, the co-exposure with RES didn’t result in 
a protection for the cell line from the mycotoxins, resulting in an increase in cytotoxicity 
at sub-toxic doses of mycotoxins, unrelated with an increase in ROS production. Further 
studies should be conducted to elucidate the mechanisms underlying the toxic effects 
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observed in the co-exposures and confirm these findings in animals. These results also 
elucidated a need to better understand the interactions with other bioactive compounds 
present in the diet, and evaluate the impact on risk assessment. 
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